Dier Mardi
CIK 0001574591
SVP and CFODirector
Filings
18
Latest Mar 6, 2026
Issuers covered
5
Showing
18 of 18
Page 1
Track record
33 of 36 open-market trades scored (92% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 33 | 3% | -12.0% | -6.7% | +4.6% | -23.3% |
| 90 days | 21 | 95% | +21.2% | +24.0% | +30.4% | -13.2% |
| 180 days | 20 | 85% | +7.2% | +13.9% | +27.1% | -39.1% |
| 365 days | 5 | 40% | -8.5% | -31.5% | +32.2% | -35.9% |
Issuers
Companies where Dier Mardi has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals, Inc. | 6 | Mar 6, 2026 |
| ORIC | Oric Pharmaceuticals, Inc. | 5 | Jan 6, 2026 |
| PRLD | Prelude Therapeutics Inc | 4 | Jun 13, 2025 |
| SLRN | Acelyrin, Inc. | 2 | May 11, 2023 |
| RARE | Ultragenyx Pharmaceutical Inc. | 1 | Mar 3, 2022 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|